Multiplikator Forward P/S: NeuroPace (NPCE)
NeuroPace, Inc. (NPCE) is implementing AI-powered neurostimulators for the autonomous correction of epileptic seizures. Production relies on robotic lines featuring optical quality control. The expected P/S valuation demonstrates the model's resilience, while 4.20 records a new level mark. The absence of competitors allows the company to exercise pricing power by setting premium rates for insurance organizations and clinics.
Ringkesan rincian data analitis NeuroPace Medical (NPCE)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal NeuroPace, Inc.|NPCE - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal NeuroPace, Inc.|NPCE - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku NeuroPace Medical|NPCE - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan NeuroPace|Rasio cepet neuropace.com
- rincian asil keuangan lan kelipatan valuasi:
NPCE - Penghasilan resik perusahaan|Bathi sing dikarepake NeuroPace, Inc.|NPCE - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi NeuroPace Corp|NPCE - Pangali PEG|Pangali EV/EBITDA NeuroPace Medical|NPCE - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan NeuroPace|NPCE - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan neuropace.com|NPCE - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep NeuroPace, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:NPCE (NeuroPace)
NeuroPace, Inc. (NPCE) specializes in the production of critical neurosurgical equipment, which renders the company's revenue resilient to macroeconomic shocks. By analyzing the projected P/S trend, an investor assesses the ratio of current market capitalization to expected sales, determining the extent to which the market is willing to pay a premium for future growth given the defensive nature of the business and long-term technology adoption cycles.
Karo sapa NeuroPace, Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|TCMD - Rasio rega marang prakiraan pendapatan|SNWV: Rasio rega marang prakiraan pendapatan|OM (Outset) - Multiplikator forward rega marang pendapatan|Electromed - Rega forward marang dodolan|LNSR (LENSAR, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep avitamedical.com RCEL|Rasio rega marang prakiraan pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Prakiraan rega marang pendapatan|EDAP TMS - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|beyondair.net (XAIR) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan PFSA|SSKN (STRATA Skin Sciences Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep glucotrack.com GCTK|Multiplikator forward rega marang pendapatan NAOV (NanoVibronix)|Multiplikator Forward P/S Venus Concept Corporation (VERO)|Rasio rega marang prakiraan pendapatan Nuwellis, Inc. NUWE|Rega forward marang dodolan AEMD|ASXC - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Avinger Inc.|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CUTR (Cutera Inc)|KNW (Know Labs, Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S inarimedical.com|Multiplikator Forward P/S NVRO|Multiplikator forward rega marang pendapatan reshapelifesciences.com RSLS|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
